StockData
Adagene Inc. logo

Adagene Inc. (ADAG) income statement

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.82+0.34 (+22.97%)

Close on Nov 18, 2026Market cap $107.80MP/E –Yield –

Adagene Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-279.5%
Net margin
-229.6%
Return on equity, FY2025
-41.0%

Financial strength

Current ratio
5.02
Debt to equity
0.06
Debt to assets
4.3%
Cash to current liabilities
485.2%

Valuation

P/E ratio
–
Price to sales
14.05
Price to book
1.21
Dividend yield
–

See a number that looks wrong?